%0 Journal Article
%T Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study
%A Chuanmiao Xie
%A Feng Han
%A Haiqiang Mai
%A Haoyuan Mo
%A Huai Liu
%A Jianwei Wang
%A Jun Ma
%A Kajia Cao
%A Ling Guo
%A Linquan Tang
%A Liting Liu
%A Lu Zhang
%A Musheng Zeng
%A Na Liu
%A Pan Wang
%A Qingmei He
%A Qingnan Tang
%A Qiuyan Chen
%A Rui Sun
%A Shanshan Guo
%A Xiang Guo
%A Xiaoqun Yang
%A XueSong Sun
%A Yanfang Ye
%A Yang Li
%A Ying Guo
%A Yingqin Li
%A YuJing Liang
%A Yunxian Mo
%J Archive of "Cancer Communications".
%D 2018
%R 10.1186/s40880-018-0330-z
%X The online version of this article (10.1186/s40880-018-0330-z) contains supplementary material, which is available to authorized users
%K Nasopharyngeal carcinoma
%K Famitinib
%K Concurrent chemoradiotherapy
%K Phase I
%K dynamic contrast-enhanced ultrasound
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235389/